Staging laparotomy (SL) was introduced into the management of patients with Hodgkin's disease in about 1959 as a means of detecting occult intraabdominal disease, and in recent years its role has diminished and become more clearly defined. (Glees et al., 1982) Some patients with non-Hodgkin's lymphoma (NHL), but only a minority, have been staged in this way also, the personal series reported here probably being the largest in this country. SL will indeed detect occult intra-abdominal disease in patients with apparently localised NHL, converting in the order of 10-30% of patients from clinical stage (CS) I or II to pathological stage (PS) III or IV. (Veronesi et al., 1974; Kim & Dorfman, 1974; Bitran et al., 1977; Goffinet et al., 1977; Heifetz et al., 1980; Toonkel et al., 1980) . It became apparent in the late 1970s, however, that the use of SL in patients with NHL in an analogous fashion to its use in Hodgkin's disease was inappropriate. The published results of SL from Stanford and from other centres indicated that SL was of limited value in view of the frequently disseminated nature of the disease at presentation, the success of less invasive staging techniques in detecting systemic involvement, and the failure of non-systemic therapy to prevent early relapse. (Dick et al., 1974; Fraser et al., 1979; Ribas-Mundo & Rosenberg, 1979; Horwich & Peckham, 1983 Clinical staging according to the Ann Arbor criteria (Carbone et al., 1971 (Table III) . Patients with PS I disease did well, with Pathological stage "B" refers to the presence of "B symptoms", and "E" refers to extranodal disease (Carbone et al., 1971) . no relapses following radiotherapy. This may reflect the selected nature of our pathologically staged patients, as other series report a 5-year relapse free survival of only 40-60% for CS I patients treated with radiotherapy alone. (Jones et al., 1973; Peckham et al., 1975; Hellman et al., 1977; Reddy et al., 1977; Chen et al., 1979; Lester et al., 1982) . Even if our 11 CS I patients had not been laparotomised, at least 8 would have been long survivors. Patients with PS III or IV disease were usually treated with combination chemotherapy and involved field radiotherapy, and had a 5-year relapse free survival of 3/21 patients (14%). Relapse and survival also correlated with histological subtype, with higher relapse rates in patients with "bad risk" lymphoma. (Rosenberg, 1979; Horwich & Peckham, 1983) . (Table IV) When a "diagnostic" laparotomy for suspected lymphoma is performed, or a lymphoma is found at an emergency laparotomy for an intra-abdominal complication, there is no virtue in performing a splenectomy, but a liver biopsy and biopsy of palpably abnormal nodes or mesenteric nodes is recommended. The most useful staging procedure is probably bone marrow biopsy from a number of sites, and if this can be performed under general anaesthesia at the time of laparotomy then the patient will be grateful. "Second look" SL is not justified as chemotherapy is usually the treatment of choice for relapsed disease, and patients can be adequately followed up using non-operative staging techniques. aRappaport (1966) classification.
